These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 6729984

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic significance of serum cholesterol in childhood nephrotic syndrome.
    Okoro BA.
    East Afr Med J; 1987 Dec; 64(12):845-8. PubMed ID: 3505207
    [No Abstract] [Full Text] [Related]

  • 4. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO, Agbedana EO, Kadiri S, Taylor GO.
    Afr J Med Med Sci; 1999 Dec; 28(1-2):97-100. PubMed ID: 12953996
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of lipoprotein lipase by plasma from children with the steroid responsive nephrotic syndrome.
    Vermylen C, Levin M, Barratt TM, Muller DP.
    Pediatr Res; 1987 Aug; 22(2):197-200. PubMed ID: 3658546
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diffusible fraction of cholesterol in serum of patients with nephrotic syndrome.
    Markiewicz K, Lutz W, Walasek L.
    Acta Med Pol; 1975 Aug; 16(3):151-8. PubMed ID: 1180118
    [No Abstract] [Full Text] [Related]

  • 12. Childhood nephrotic syndrome in Enugu, Nigeria.
    Okoro BA, Okafor HU, Nnoli LU.
    West Afr J Med; 2000 Aug; 19(2):137-41. PubMed ID: 11070750
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA, Davies RW.
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility of non-HDL fraction to oxidation in experimental nephrotic syndrome.
    Dirican M, Taş S, Sarandöl E, Tokullugil HA.
    Kobe J Med Sci; 1998 Dec; 44(5-6):235-45. PubMed ID: 10401226
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum-cholesterol-binding reserve in patients with the nephrotic syndrome.
    Perez GO, Levine S, Gomez E, Hsia SL.
    Nephron; 1979 Dec; 24(3):146-9. PubMed ID: 492425
    [Abstract] [Full Text] [Related]

  • 19. Decreased antioxidant activity in hypercholesterolemic children with nephrotic syndrome.
    Zachwieja J, Bobkowski W, Dobrowolska-Zachwieja A, Zaniew M, Maciejewski J.
    Med Sci Monit; 2003 Jun; 9(6):CR235-9. PubMed ID: 12824952
    [Abstract] [Full Text] [Related]

  • 20. [Serum lipid levels in children and teenagers from Concepción, Chile].
    Casanueva V, Cid X, Chiang MT, Román R, Milos C, Reyes M, Venegas H, Casanueva P.
    Rev Med Chil; 1996 Dec; 124(12):1453-61. PubMed ID: 9334479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.